Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Nuedexta, Neurodex, 07-AVR-123 OLE
Generic Name: Dextromethorphan with Quinidine
A dextromethorphan-quinidine combination was studied for its effect on inappropriate laughing and crying episodes experienced by some patients with brain injury or brain degeneration due to certain diseases. The incongruous laughing and crying episodes are due to pseudobulbar affect.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Emotional lability | 37 | 11 |
|
|
|
|
|
| ALS (Amyotrophic Lateral Sclerosis) | 8 | 2 |
|
|
|||
| emotions, to stop uncontrollable laughing and crying | 8 | 4 |
|
|
|
||
| Back pain | 1 | 1 |
|
||||
| Support brain health | 1 | 0 | |||||
| Doctor recommendation | 1 | 0 |
See all 47 patients currently taking Dextromethorphan with Quinidine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Dextromethorphan with Quinidine
| Diarrhea | 2 | |
|---|---|---|
| Fatigue | 1 | |
| Dizziness | 1 | |
| Thrush | 1 | |
| Sleepiness | 1 |
Frequently reported dosages based on patients currently taking Dextromethorphan with Quinidine. See all 16 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 4 | ||
| Side effects too severe | 3 | ||
| Expense | 2 | ||
| Course of treatment ended | 2 |
See all 9 patients who’ve stopped taking Dextromethorphan with Quinidine
Adherence
Taking treatment as prescribed
Adherence of Dextromethorphan with Quinidine
Always |
16 | 76% |
|
|---|---|---|---|
Usually |
4 | 19% |
|
Sometimes |
0 | 0% |
|
Never |
1 | 5% |
|
Burden
Difficulty being on treatment
Burden of Dextromethorphan with Quinidine
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
1 | 5% |
|
A little |
2 | 10% |
|
Not at all |
18 | 86% |
|
Cost
Paid out of pocket
Cost of Dextromethorphan with Quinidine
$200+ |
1 | 8% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
3 | 23% |
|
$25-49 |
6 | 46% |
|
< $25 |
3 | 23% |
|
Report created on May 28, 2012.